Strides receives USFDA approval for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules

Strides receives USFDA approval for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules     Strides Pharma Science Limited (Strides) today announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, 50 mg/325 mg/40 mg/30 mg from the United States Food & Drug Administration (USFDA). The product is a generic version of Fioricet® with Codeine Capsules, 50 mg/325 mg/40 mg/30 mg, of Teva Branded Pharmaceutical Product R&D, Inc. According to IQVIA MAT May 2020 data, the US…

Read More

TCS to Help Tryg Transform its IT Core and Enable Future Growth

TCS to Help Tryg Transform its IT Core and Enable Future Growth       Tata Consultancy Services (TCS), a leading global IT services, consulting and business solutions organization, has expanded its decade-long partnership with Tryg, one of the largest non-life insurance companies in the Nordic region, to help the latter adopt a future-ready technology stack and IT operating model that will accelerate its digital transformation journey. As part of the expanded partnership, TCS will provide mainframe hosting and operations, and implement a future-proof hybrid cloud architecture that leverages the…

Read More

Maruti Suzuki partners with Axis Bank for easy finance solutions

Maruti Suzuki partners with Axis Bank for easy finance solutions       Maruti Suzuki India Limited has collaborated with Axis Bank to offer easy financing options for the potential car buyers. Axis Bank is one of the key partners of Maruti Suzuki for inventory as well as retail financing solutions. As a part of the tie-up, Axis Bank will offer attractive flexi EMI options to ease the liquidity and repayment stress of customers during these tough times. Axis Bank offers auto loans to a wide category of customer segments:…

Read More

Hindustan Unilever completes acquisition of Vwash from Glenmark Pharmaceuticals

Hindustan Unilever completes acquisition of Vwash from Glenmark Pharmaceuticals     Hindustan Unilever Limited (HUL) announced that it hascompleted the acquisition of intimate  hygiene brand VWash from Glenmark Pharmaceuticals Ltd. This acquisition was announced on March 23, 2020 and was subject to certain closing conditions, which have now been fulfilled. VWash was launched by Glenmark in 2013 and the brand has established itself as the market leader in the female intimate hygiene category backed by strong product proposition, consumer endorsements and brand building investments. HUL has acquired intellectual property rights…

Read More

Vodafone Idea Limited’s equity stake in Indus Towers Limited (“Indus”)

Vodafone Idea Limited’s equity stake in Indus Towers Limited (“Indus”)       Further to our communication dated 24 April 2020 in relation to the merger of Indus (in which the Company is holding 11.15% equity stake) with Bharti Infratel Limited (“Merger”), we hereby wish to inform that the parties have agreed to further extend the extended Long Stop Date of 24 June 2020 to 31 August 2020, so as to complete the remaining conditions precedent including the pre-closing adjustments. The consummation of the Merger is subject to mutual agreement…

Read More

DIAGEO INDIA LAUNCHES ‘RAISING THE BAR’, A RS. 75 CR. REVIVAL AND RECOVERY PROGRAMME TO SUPPORT BARS, PUBS AND RESTAURANTS SERVING ALCOHOL

DIAGEO INDIA LAUNCHES ‘RAISING THE BAR’, A RS. 75 CR. REVIVAL AND RECOVERY PROGRAMME TO SUPPORT BARS, PUBS AND RESTAURANTS SERVING ALCOHOL   Diageo India today announced ‘Raising the Bar’, a 75-crore programme committed to support bars, pubs and restaurants serving alcohol to welcome customers back and recover following the COVID-19 pandemic. “Raising the Bar” will be a two year programme to support the revival and recovery of qualifying bars, pubs and restaurants serving alcohol across New Delhi, Mumbai, Bengaluru and other cities. Diageo designed the “Raising the Bar” programme…

Read More

TCS Deploys Digital Solution Remotely to Help Adani Ports Transform Mundra Operations

TCS Deploys Digital Solution Remotely to Help Adani Ports Transform Mundra Operations     Tata Consultancy Services (TCS),a leading global IT services, consulting and business solutions organization, announced that it has successfully deployed TCS DynaPORT, a state-of-the-art terminal operating system at the Mundra CT4 terminal for Adani Ports and Special Economic Zone (APSEZ) Limited, India’s largest private port operator and end-to-end logistics provider. The deployment was completed remotely, while under a lockdown, leveraging TCS’ Secure Borderless Workspaces™ (SBWS™) model. APSEZ operates 11 strategically located ports and terminals that represent 24…

Read More

Alembic Pharmaceuticals receives USFDA Tentative Approval for Rivaroxaban Tablets, 10 mg, 15 mg, and 20 mg.

Alembic Pharmaceuticals receives USFDA Tentative Approval for Rivaroxaban Tablets, 10 mg, 15 mg, and 20 mg.     Alembic Pharmaceuticals Limited today announced that the Company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Rivaroxaban Tablets, 10 mg, 15 mg, and 20 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Xarelto Tablets, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals, Inc. (Janssen). Alembic Pharmaceuticals announces USFDA Final Approval for Doxycycline Hyclate…

Read More

L&T Hydrocarbon Engineering signs MoU with KBR for Refinery and Petrochemical Projects

L&T Hydrocarbon Engineering signs MoU with KBR for Refinery and Petrochemical Projects     L&T Hydrocarbon Engineering (LTHE), a wholly-owned subsidiary of Larsen 0 Toubro (L&T), has signed a memorandum of understanding with KBR to build Modular Process Plants for refinery and petrochemical projects Under the terms of the agreement, KBR and LTHE will collaborate to develop business opportunities and LTHE will exclusively bid for KBR’s solid acid alkylation technology (K-SAATTm), solvent de-asphalting technology (ROSE®) and catalytic olefins technology (K-COTTm) for global projects with special emphasis on India, South East…

Read More

Alembic Pharmaceuticals receives USFDA Final Approval for Deferasirox Tablets 180 mg

Alembic Pharmaceuticals receives USFDA Final Approval for Deferasirox Tablets, 180 mg.     Alembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Deferasirox Tablets, 180 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Jadenu Tablets, 180 mg, of Novartis Pharmaceuticals Corporation (Novartis). Deferasirox tablets are indicated for treatment of Chronic Iron Overload Due to Blood Transfusions (Transfusional Iron Overload) and for treatment of Chronic Iron Overload…

Read More